Access Resources
1811 - 1820 of 7540 Results
Title
Year
- Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging2022RESTRICTEDTitle: Investigating Simultaneity for Deep Learning–Enhanced Actual Ultra-Low-Dose Amyloid PET/MR ImagingJournal Name: American Journal of NeuroradiologyPublisher: American Society of Neuroradiology (ASNR)Vol: 43Issue #: 3Start Page: 354End Page: 360Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3174/ajnr.a7410Best OA location URL: https://www.ajnr.org/content/ajnr/43/3/354.full.pdfCitation Count: 1
- Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis2022RESTRICTEDTitle: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid HomeostasisJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 10Start Page: 2116End Page: 2130Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022Best OA location URL: https://www.jneurosci.org/content/jneuro/42/10/2116.full.pdfCitation Count: 7
- Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations2022RESTRICTEDTitle: Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinationsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-28087-0Best OA location URL: https://www.nature.com/articles/s41467-022-28087-0.pdfCitation Count: 15
- Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers2022RESTRICTEDTitle: Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 91Issue #: 3Start Page: 424End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26302Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857042Citation Count: 47
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2022RESTRICTEDTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 48
- Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patients2022RESTRICTEDTitle: Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patientsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03032-5Best OA location URL: https://www.nature.com/articles/s42003-022-03032-5.pdfCitation Count: 17
- No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological Significance2022RESTRICTEDTitle: No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological SignificanceJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 653End Page: 653Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28935Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940713Citation Count: 4
-
RESTRICTEDTitle: Down‐Regulation of Dopamine Transporter in Early Premotor PhasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 663End Page: 664Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28924Citation Count: 0
-
RESTRICTEDTitle: Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or SeverityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 651End Page: 652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28929Citation Count: 4
- A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study2022RESTRICTEDTitle: A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative StudyJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 1Start Page: 137End Page: 151Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202457Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202457?id=journal-of-parkinsons-disease%2Fjpd202457Citation Count: 11